Taken together, our findings provide new insights into the role of SerpinB2, which was upregulated by miR-200c/141 overexpression, in promoting BCC lung and LN metastasis, and suggest that SerpinB2 could be used to assess metastasis risk in BC patients. The gene discussed is SERPINB2; the disease is skin basal cell carcinoma.